PNTG The Pennant Group, Inc.
Stock · NasdaqGS · United States · Healthcare · US70805E1091
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by The Pennant Group, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
36.36 USD
-9.10%
52-week range
23.50 – 44.24
Dividend yield—
Market cap1.3B
NowoTrade score
55 Grade A
Price history
Daily prices in USD.
Updated 07 Nov 2026 09:41. Information, not advice.
Results
Next results
24 Feb 2027
in 109 days · 16:00 · estimate 0.37
Last results
0.35 vs 0.35 estimated
04 Nov 2026 · Miss -1.2%
Beat the estimate
8 of 12
1 missed · 3 in line
Average surprise
+6.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 24 Feb 2027 16:00 | 0.37 | — | — | Upcoming |
| 04 Nov 2026 16:00 | 0.35 | 0.35 | -1.2% | Miss |
| 05 Aug 2026 16:00 | 0.33 | 0.36 | +9.1% | Beat |
| 06 May 2026 16:00 | 0.31 | 0.32 | +4.9% | Beat |
| 25 Feb 2026 16:00 | 0.32 | 0.34 | +7.7% | Beat |
| 05 Nov 2025 16:00 | 0.29 | 0.30 | +4.7% | Beat |
| 06 Aug 2025 16:00 | 0.27 | 0.27 | 0.0% | In line |
| 06 May 2025 16:00 | 0.24 | 0.27 | +13.7% | Beat |
| 27 Feb 2025 16:00 | 0.24 | 0.24 | 0.0% | In line |
| 06 Nov 2024 16:00 | 0.23 | 0.26 | +13.0% | Beat |
| 06 Aug 2024 16:00 | 0.22 | 0.24 | +11.6% | Beat |
| 06 May 2024 16:00 | 0.17 | 0.20 | +17.7% | Beat |
| 28 Feb 2024 16:00 | 0.22 | 0.22 | 0.0% | In line |
| 07 Nov 2023 16:00 | 0.19 | 0.20 | +3.9% | Beat |
| 08 Aug 2023 16:00 | 0.16 | 0.18 | +10.2% | Beat |
| 04 May 2023 16:00 | 0.14 | 0.13 | -9.3% | Miss |
| 23 Feb 2023 16:00 | 0.18 | 0.18 | -1.1% | Miss |
| 07 Nov 2022 16:00 | 0.18 | 0.14 | -23.1% | Miss |
| 08 Aug 2022 16:00 | 0.14 | 0.14 | -1.8% | Miss |
| 09 May 2022 16:00 | 0.08 | 0.10 | +21.5% | Beat |
| 28 Feb 2022 16:00 | 0.15 | 0.07 | -52.5% | Miss |
| 08 Nov 2021 16:00 | 0.18 | 0.11 | -38.9% | Miss |
| 09 Aug 2021 01:00 | 0.21 | 0.17 | -19.1% | Miss |
| 06 May 2021 16:00 | 0.19 | 0.11 | -43.1% | Miss |
| 24 Feb 2021 16:00 | 0.20 | 0.17 | -16.4% | Miss |
| 10 Nov 2020 16:00 | 0.17 | 0.18 | +5.9% | Beat |
| 11 Aug 2020 16:00 | 0.12 | 0.24 | +108.7% | Beat |
| 13 May 2020 16:00 | 0.13 | 0.16 | +23.1% | Beat |
| 04 Mar 2020 16:00 | 0.16 | 0.16 | 0.0% | In line |
| 12 Nov 2019 16:00 | 0.12 | 0.16 | +33.3% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 947.7M | +36.3% | 29.6M | 3.1% | 0.84 | +20.0% | 36.3M |
| 2024 | 695.2M | +27.6% | 22.6M | 3.2% | 0.70 | +59.1% | 30.3M |
| 2023 | 544.9M | +15.1% | 13.4M | 2.5% | 0.44 | +100.0% | 25M |
| 2022 | 473.2M | — | 6.6M | 1.4% | 0.22 | — | -5.1M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 27 Aug 2026 | 37.89 | 38.64 | 37.38 | 37.82 | -1.20% | 336,700 | |
| 26 Aug 2026 | 38.29 | 38.77 | 38.19 | 38.28 | +0.08% | 178,100 | |
| 25 Aug 2026 | 38.98 | 39.50 | 37.73 | 38.25 | -1.65% | 226,200 | |
| 24 Aug 2026 | 39.15 | 39.60 | 38.68 | 38.89 | +0.03% | 226,900 | |
| 21 Aug 2026 | 39.00 | 39.24 | 38.66 | 38.88 | -0.31% | 341,300 | |
| 20 Aug 2026 | 38.82 | 39.56 | 38.75 | 39.00 | -0.36% | 161,300 | |
| 19 Aug 2026 | 39.76 | 40.00 | 38.77 | 39.14 | -0.66% | 217,400 | |
| 18 Aug 2026 | 39.18 | 40.27 | 39.00 | 39.40 | +0.56% | 185,100 | |
| 17 Aug 2026 | 39.57 | 39.57 | 38.51 | 39.18 | -0.36% | 222,400 | |
| 14 Aug 2026 | 38.69 | 39.45 | 38.15 | 39.32 | +1.76% | 226,400 | |
| 13 Aug 2026 | 38.88 | 39.22 | 38.49 | 38.64 | +0.68% | 236,600 | |
| 12 Aug 2026 | 38.25 | 38.85 | 38.11 | 38.38 | +0.55% | 301,000 | |
| 11 Aug 2026 | 39.92 | 40.55 | 37.96 | 38.17 | -3.71% | 226,800 | |
| 10 Aug 2026 | 38.54 | 40.21 | 38.39 | 39.64 | +1.64% | 220,800 | |
| 07 Aug 2026 | 38.68 | 39.15 | 38.29 | 39.00 | -0.15% | 180,500 | |
| 06 Aug 2026 | 37.85 | 39.81 | 37.40 | 39.06 | +0.64% | 364,700 | |
| 05 Aug 2026 | 38.86 | 39.18 | 38.01 | 38.81 | +0.52% | 684,600 | |
| 04 Aug 2026 | 40.05 | 40.05 | 38.36 | 38.61 | -3.91% | 551,200 | |
| 03 Aug 2026 | 40.62 | 41.46 | 40.15 | 40.18 | -0.35% | 255,500 | |
| 31 Jul 2026 | 40.87 | 41.20 | 39.45 | 40.32 | -1.97% | 217,100 | |
| 30 Jul 2026 | 40.75 | 41.90 | 40.54 | 41.13 | +0.12% | 179,100 | |
| 29 Jul 2026 | 42.01 | 42.19 | 40.89 | 41.08 | -2.24% | 258,900 | |
| 28 Jul 2026 | 41.34 | 42.69 | 41.13 | 42.02 | +1.64% | 266,900 | |
| 27 Jul 2026 | 41.50 | 41.88 | 41.06 | 41.34 | +0.44% | 156,900 | |
| 24 Jul 2026 | 39.88 | 41.56 | 39.50 | 41.16 | +3.39% | 175,900 |
Page 3 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- What The Pennant Group (PNTG) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 06 Nov 2026 15:14
- Pennant Group (PNTG) Earnings Beat Keeps Fair Value In Focus (opens in a new tab) Simply Wall St. · 06 Nov 2026 12:16
- Pennant Group Inc (PNTG) Q3 2026 Earnings Call Highlights: Revenue Jumps 32% as Home Health and ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 01:19
- Conference call: Pennant Gr Affirms FY2026 Adj EPS Guidance of $1.34-$1.41 vs $1.40 Est; Affirms FY2026 Sales Guidance of $1.171B-$1.190B vs $1.184B Est (opens in a new tab) Benzinga · 05 Nov 2026 18:04
- Pennant Gr Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 05 Nov 2026 14:09
- Oppenheimer Maintains Outperform on Pennant Gr, Raises Price Target to $50 (opens in a new tab) Benzinga · 05 Nov 2026 13:51
- The Pennant Group (NASDAQ:PNTG) beats Q3 2026 sales expectations (opens in a new tab) StockStory · 04 Nov 2026 22:44
- Pennant Reports Third Quarter 2026 Results (opens in a new tab) 04 Nov 2026 21:05
- Pennant Announces Third Quarter 2026 Earnings Release and Call (opens in a new tab) 03 Nov 2026 23:30
- Pennant Group (PNTG) Acquires Mainplace Senior Living Real Estate in Orange (opens in a new tab) Simply Wall St. · 25 Sep 2026 17:10
- Are You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great Choice (opens in a new tab) Zacks · 21 Sep 2026 17:00
- The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last? (opens in a new tab) Zacks · 17 Sep 2026 08:16
- All You Need to Know About The Pennant Group (PNTG) Rating Upgrade to Buy (opens in a new tab) Zacks · 14 Sep 2026 17:00
- Senior Health, Home Health & Hospice Stocks Q2 Results: Benchmarking The Pennant Group (NASDAQ:PNTG) (opens in a new tab) StockStory · 04 Sep 2026 16:26
- 3 Reasons to Avoid PNTG and 1 Stock to Buy Instead (opens in a new tab) StockStory · 31 Aug 2026 17:46
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 40.00 USD
- Market cap
- 1.3B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 11.8 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 8.9 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 3.7 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Heavy debt: net debt is 5.6× EBITDA
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 36× | Weak | 31.09× |
| P/E (forward) | 22.91× | Fair | 14.98× |
| Price / book | 3.41× | Weak | 3.94× |
| Price / sales | 1.09× | Good | 3.37× |
| EV / EBITDA | 22.97× | Weak | 12.96× |
| Free cash flow yield | -0.6% | Weak | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 19.4% | Weak | 59.2% |
| Operating margin | 5.8% | Weak | 7.4% |
| Net margin | 3.1% | Weak | 3.4% |
| Return on equity | 11.2% | Fair | 5.7% |
| Return on assets | 5% | Fair | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 26% | Good | 10.8% |
| EPS growth / year | 56.3% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.16× | Fair | 0.46× |
| Net debt / EBITDA | 5.63× | Weak | 1.5× |
| Interest cover | 7.62× | Fair | 3.26× |
| Current ratio | 1.18× | Fair | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow PNTG and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.